Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

EDOXABAN vs FONDAPARINUX: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

EDOXABAN vs FONDAPARINUX: Safety Overview

Metric EDOXABAN FONDAPARINUX
Total FAERS Reports 8,334 2,230
Deaths Reported 992 308
Death Rate 11.9% 13.8%
Hospitalizations 4,729 1,141
Average Patient Age 77.2 yrs 63.2 yrs
% Female Patients 46.5% 56.5%
FDA Approval Date Jan 8, 2015 Aug 19, 2024
Manufacturer Daiichi Sankyo Inc. Dr. Reddy's Laboratories Limited
Route ORAL SUBCUTANEOUS
Marketing Status Prescription Prescription